Press Releases
Samsung Biologics hosts 12th Annual General Meeting of Shareholders
Samsung Biologics hosted its 12th Annual General Meeting of Shareholders at the company's headquarters in Songdo today.
Immediately following the Annual General Meeting of Shareholders, President and CEO John Rim was elected as Chair of the Board of Directors, to further helm the company's long-term growth strategy while expanding its leadership position as a top-tier global CDMO.
Samsung Biologics hosted its 12th Annual General Meeting of Shareholders at the company's headquarters in Songdo today.
Immediately following the Annual General Meeting of Shareholders, President and CEO John Rim was elected as Chair of the Board of Directors, to further helm the company's long-term growth strategy while expanding its leadership position as a top-tier global CDMO.